Center for Single Cell Genomics

Since its founding, JCVI has been a leader in the development of cutting-edge laboratory and computational genomics technologies, including methods for sequencing and analyzing the expressed genome from single cells. In 2017, JCVI established the Center for Single Cell Genomics, led by La Jolla Campus Director Richard Scheuermann. The Center has extended and applied these cutting-edge single cell genomics technologies in several exciting areas. In collaboration with the Allen Institute for Brain Science, JCVI investigators applied single cell RNA sequencing and artificial intelligence machine learning analytics to cells isolated from post-mortem human brain and discovered ten distinct inhibitory neuron subtypes, including the characterization of a novel group of interneurons with human-specific features never described in rodents.

Center for Single Cell Genomics

Since its founding, JCVI has been a leader in the development of cutting-edge laboratory and computational genomics technologies, including methods for sequencing and analyzing the expressed genome from single cells. In 2017, JCVI established the Center for Single Cell Genomics, led by La Jolla Campus Director Richard Scheuermann. The Center has extended and applied these cutting-edge single cell genomics technologies in several exciting areas. In collaboration with the Allen Institute for Brain Science, JCVI investigators applied single cell RNA sequencing and artificial intelligence machine learning analytics to cells isolated from post-mortem human brain and discovered ten distinct inhibitory neuron subtypes, including the characterization of a novel group of interneurons with human-specific features never described in rodents.

You are here

The discovery of human-specific neuron cell types will help scientists determine how the function of our brain makes us uniquely human. By applying single cell RNA sequencing to blood cells from healthy volunteers, JCVI investigators have also found that the abundance of a novel blood cell subtype could predict which individuals would respond to a single dose of the Hepatitis B vaccine. These findings will allow investigators to design pre-conditioning regimens that could increase vaccination efficacy in the future. And by applying these single cell genomics technologies to cells isolated from the cerebrospinal fluid of multiple sclerosis patients, JCVI investigators have discovered abnormal cell types associated with disease pathogenesis. These findings provide new information about the causes of autoimmune diseases, and will be used to identify novel targets for new therapies.

Key Staff

Brian Aevermann, MS
Bioinformatics Analyst
Frank Harrison
Lab Operations Manager
Todd P. Michael, PhD
Director of Informatics; Professor
Mark Novotny
Research Associate III
Richard H. Scheuermann, PhD
Director, La Jolla Campus; Professor